Literature DB >> 19768407

DNA vaccines against influenza viruses.

Jin Hyang Kim1, Joshy Jacob.   

Abstract

As an attractive alternative to conventional vaccines, DNA vaccines play a critical role in inducing protection against several infectious diseases. In this review, we discuss the advantages that DNA vaccines offer in comparison to conventional protein-based vaccines. We discuss strategies to improve the potency and efficacy of DNA vaccines. Specifically, we focus on the potential use of DNA-based vaccines to elicit broad-spectrum humoral and cellular immunity against influenza virus. Finally, we discuss the advances made in the use of DNA vaccines to prevent avian H5N1 influenza.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19768407     DOI： 10.1007/978-3-540-92165-3_10

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN： 0070-217X            Impact factor:   4.291


  14 in total

Review 1.  H5N1 vaccines in humans.

Authors:  Mariana Baz; Catherine J Luke; Xing Cheng; Hong Jin; Kanta Subbarao
Journal:  Virus Res       Date:  2013-05-28       Impact factor: 3.303

2.  Experimental vaccines against potentially pandemic and highly pathogenic avian influenza viruses.

Authors:  Alaina J Mooney; S Mark Tompkins
Journal:  Future Virol       Date:  2013-01-01       Impact factor: 1.831

3.  Built-in adjuvanticity of genetically and protein-engineered chimeric molecules for targeting of influenza A peptide epitopes.

Authors:  Nikola S Kerekov; Iva I Ivanova; Nikolina M Mihaylova; Maria Nikolova; Jozsef Prechl; Andrey I Tchorbanov
Journal:  Immunol Res       Date:  2014-10       Impact factor: 2.829

4.  Refining the approach to vaccines against influenza A viruses with pandemic potential.

Authors:  Rita Czako; Kanta Subbarao
Journal:  Future Virol       Date:  2015       Impact factor: 1.831

Review 5.  Current advancements and potential strategies in the development of MERS-CoV vaccines.

Authors:  Naru Zhang; Shibo Jiang; Lanying Du
Journal:  Expert Rev Vaccines       Date:  2014-04-26       Impact factor: 5.217

6.  Comparison of the Protective Efficacy of Neutralizing Epitopes of 2009 Pandemic H1N1 Influenza Hemagglutinin.

Authors:  Bo Peng; Na Peng; Yanan Zhang; Fenghua Zhang; Xuguang Li; Haiyan Chang; Fang Fang; Fuyan Wang; Fangguo Lu; Ze Chen
Journal:  Front Immunol       Date:  2017-08-31       Impact factor: 7.561

Review 7.  Novel Platforms for the Development of a Universal Influenza Vaccine.

Authors:  Arun Kumar; Trine Sundebo Meldgaard; Sylvie Bertholet
Journal:  Front Immunol       Date:  2018-03-23       Impact factor: 7.561

Review 8.  Developing Universal Influenza Vaccines: Hitting the Nail, Not Just on the Head.

Authors:  Lidewij C M Wiersma; Guus F Rimmelzwaan; Rory D de Vries
Journal:  Vaccines (Basel)       Date:  2015-03-26

9.  Functional growth inhibition of influenza A and B viruses by liquid and powder components of leaves from the subtropical plant Melia azedarach L.

Authors:  Kuniaki Nerome; Kazufumi Shimizu; Shiori Zukeran; Yasuhiro Igarashi; Kazumichi Kuroda; Shigeo Sugita; Toshikatsu Shibata; Yasuhiko Ito; Reiko Nerome
Journal:  Arch Virol       Date:  2018-04-09       Impact factor: 2.574

Review 10.  COVID-19 vaccine: A recent update in pipeline vaccines, their design and development strategies.

Authors:  Kajal Rawat; Puja Kumari; Lekha Saha
Journal:  Eur J Pharmacol       Date:  2020-11-25       Impact factor: 4.432
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.